Bicara Therapeutics Inc. Common Stock (BCAX) financials · $1.51B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Bicara Therapeutics Inc. Common Stock (BCAX) $1.51B cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$155.6M | -$82.4M |
| Net Income | -$137.9M | -$68.0M |
| EPS (Diluted) | -$2.52 | -$4.05 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $431.0M | $510.0M |
| Current Assets | $422.1M | $502.5M |
| Cash & Equivalents | $96.7M | $489.7M |
| PP&E | $330.0K | $155.0K |
| Total Liabilities | $29.5M | $18.1M |
| Current Liabilities | $28.9M | $18.0M |
| Shareholders' Equity | $401.5M | $491.9M |
| Retained Earnings | -$359.0M | -$221.0M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$106.8M | -$74.8M |
| CapEx | $280.0K | $71.0K |
| Investing Cash Flow | -$318.5M | -$9.00K |
| Financing Cash Flow | $32.3M | $334.0M |
| Net Change in Cash | -$393.0M | $259.3M |
| Free Cash Flow | -$107.1M | -$74.8M |
FAQ
What is BCAX P/E and revenue?
Bicara Therapeutics Inc. Common Stock (BCAX) $1.51B cap.
What is BCAX revenue?
BCAX income-statement cache has no revenue figure yet.
Is BCAX profitable?
Bicara Therapeutics Inc. Common Stock last cached net income is -$137.9M (FY2025).
What are BCAX total assets?
Bicara Therapeutics Inc. Common Stock last cached total assets are $431.0M (FY2025).
What is BCAX free cash flow?
Bicara Therapeutics Inc. Common Stock last cached free cash flow is -$107.1M (FY2025).
Not investment advice. Cached statements, not a live tape.